lysine has been researched along with eicosapentaenoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dechend, R; Fiebeler, A; Haller, H; Honeck, H; Kaergel, E; Luft, FC; Muller, DN; Park, JK; Schunck, WH; Shagdarsuren, E; Theuer, J | 1 |
| Billings, FT; Brown, NJ; Milne, GL; Nian, H; Shuey, MM; Wei, S; Yu, C | 1 |
| Balvers, M; Bosi, R; Diepeveen-de Bruin, M; Headley, L; Manusama, K; Schwarm, M; Witkamp, R | 1 |
1 trial(s) available for lysine and eicosapentaenoic acid
| Article | Year |
|---|---|
In vitro dissolution behaviour and absorption in humans of a novel mixed l-lysine salt formulation of EPA and DHA.
Topics: Biological Availability; Cross-Over Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lysine | 2021 |
2 other study(ies) available for lysine and eicosapentaenoic acid
| Article | Year |
|---|---|
Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Arachidonic Acid; Eicosapentaenoic Acid; Enzyme Inhibitors; Humans; In Vitro Techniques; Kidney; Lysine; Male; Microsomes; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Renin; Transcription Factor AP-1 | 2005 |
Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery.
Topics: Acute Kidney Injury; Aged; Cohort Studies; Coronary Artery Bypass; Eicosapentaenoic Acid; Epoxide Hydrolases; Female; Genotype; Glomerular Filtration Rate; Humans; Incidence; Lysine; Male; Middle Aged; Polymorphism, Genetic | 2017 |